ArticlePeerJ2024

DLX1 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression in lung adenocarcinoma.

Yu Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.